NT-proBNP Concentrations in Mountain Marathoners

Banfi, G, Lippi, G, Susta, D, Barassi, A, Melzi d'Eril, G, Dogliotti, G, and Corsi, MM. NT-proBNP concentrations in mountain marathoners. J Strength Cond Res 24(5): 1369-1372, 2010-The 76 amino acid N-terminal proB-type natriuretic peptide (NT-proBNP) is proposed for evaluating and monitoring heart pathologies characterized by myocardial wall stress. Strenuous exercise might generate transitory ischemia, myocardial stress, and diastolic left ventricular dysfunction, possibly inducing an increase of some biochemical parameter concentrations. An alert has been claimed owing to biochemical and instrumental signs of heart dysfunction in recreational athletes during marathon races. We studied the behaviour of NT-proBNP in 15 mountain marathoners before and after a race. The concentrations of the parameter were lower than that observed in controls at rest and were similar to that observed in professional soccer and rugby players. The concentrations significantly increased after the race. NT-proBNP is low at rest in professional athletes, and the increase after physical exercise is physiological. The marathoners, even when performing races in a high-altitude environment, show NT-proBNP concentrations similar to those of athletes from other sports disciplines, characterized by low levels of effort and by a mix of aerobic and anaerobic metabolism. The increase of NT-proBNP is linked to strenuous physical exercise and to heavy heart effort, testified also by an increase of troponin I. However, the role of the NT-proBNP could be important to screen recreational and professional marathoners to avoid possible heart problems and sudden cardiac death in subjects with occult heart disease. The results of the present study are relevant to the design and evaluation of training programs for improving strength and function of professional marathoners.

[1]  G. Lippi,et al.  N-Terminal proB-type natriuretic peptide (NT-proBNP) concentrations in elite rugby players at rest and after active and passive recovery following strenuous training sessions , 2008, Clinical chemistry and laboratory medicine.

[2]  D. T. Tunstall Pedoe.  Marathon cardiac deaths : the london experience. , 2007, Sports medicine.

[3]  T. Neilan,et al.  Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running. , 2006, American journal of clinical pathology.

[4]  P. Thompson,et al.  Marathoner's heart? , 2006, Circulation.

[5]  J. Marshall,et al.  Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon , 2006, Circulation.

[6]  C. Mclachlan,et al.  Are elevations of N-terminal probrain natriuretic peptide in endurance athletes after prolonged strenuous exercise due to systemic inflammatory cytokines? , 2006, American heart journal.

[7]  T. Meyer,et al.  Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  G. Lippi,et al.  Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[9]  R. Baumgarten,et al.  Effects of a long-distance run on cardiac markers in healthy athletes , 2006, Clinical chemistry and laboratory medicine.

[10]  G. Banfi,et al.  B-type natriuretic peptide in athletes performing an Olympic triathlon. , 2005, The Journal of sports medicine and physical fitness.

[11]  G. Hess,et al.  Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[12]  G. Roi,et al.  Behaviour of haematological parameters in athletes performing marathons and ultramarathons in altitude ('skyrunners'). , 2004, Clinical and laboratory haematology.

[13]  W. Herrmann,et al.  No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete’s heart and healthy untrained controls , 2004, Heart.

[14]  D. Pedoe,et al.  Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department , 2004, British Journal of Sports Medicine.

[15]  W. Herrmann,et al.  Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. , 2003, Clinical chemistry.

[16]  I. Gritti,et al.  Pepsinogens and Gastrointestinal Symptoms in Mountain Marathon Runners , 1996, International journal of sports medicine.

[17]  G. Roi,et al.  Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. , 1994, Growth regulation.

[18]  W. Kraemer,et al.  Effects of altitude acclimatization on fluid regulatory hormone response to submaximal exercise. , 1993, Journal of applied physiology.